V. Domingo

Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor‐positive canine mammary carcinomas

S. Guil-Luna, Y. Millán, J. M. Mulas, 2017, Veterinary and comparative oncology.

Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas.

F. Guscetti, S. Guil-Luna, Y. Millán, 2011, Journal of veterinary internal medicine.

Bilateral retiform Sertoli-Leydig cell tumour in a bitch. Alpha-inhibin and epithelial membrane antigen as useful tools for differential diagnosis.

C. Reymundo, Y. Millán, J. Gómez-Laguna, 2008, Journal of comparative pathology.

Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma

J. Stenvang, N. Brünner, S. Guil-Luna, 2014, BMC Veterinary Research.